Role of the Natriuretic Peptide System in Cardiorenal Protection | Cardiology | JAMA Internal Medicine | JAMA Network
[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
December 8/22, 2003

Role of the Natriuretic Peptide System in Cardiorenal Protection

Author Affiliations

From the Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, State University of New York Health Science Center at Brooklyn and Kings County Hospital Centers of Brooklyn. The authors have no relevant financial interest in this article.

Arch Intern Med. 2003;163(22):2696-2704. doi:10.1001/archinte.163.22.2696

Significant progress has been made in the understanding of the neurohormonal factors that contribute to the progression of chronic renal and cardiac failure and the development of target-organ damage in patients with hypertension and diabetes.1-3 We herein review some of these advances, including a new therapeutic strategy for potentially enhancing cardiorenal protection in patients with these disorders.